Breast Cancer
Efficacy of chemotherapy treatments compared
Published in Women's Health Weekly, September 29th, 2005
"Certain anthracycline-containing adjuvant chemotherapy regimens are associated with improved relapse-free survival (RFS) and overall survival (OS) compared with the classic regimen of cyclophosphamide, methotrexate, and fluorouracil in women with early-stage breast cancer," according to scientists in Canada.
The study designed was described by M. N. Levine and colleagues: "Between 1989 and 1993, 710 pre-and perimenopausal women with axillary node-positive breast cancer were randomly assigned to either cyclophosphamide 75 mg/m2 orally days 1 through...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Markers associated with the invasive character of breast ductal carcinomas - Diet & Nutrition
Nutritional bar helps women to absorb calcium, vitamins - Genetic Testing
Impact of genetic testing for cancers on preventive behaviors assessed - Hypertension
Link between oral contraceptives on blood pressure elevation explored - Menopause
Use of testosterone by postmenopausal women described in paper - Anorexia Nervosa
Alterations in brain serotonin activity may be associated with anorexia nervosa - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
